The COVID-19 Vaccine Development Landscape - CGMH

to develop adjuvanted vaccines against COVID-19, and vaccine developers including GlaxoSmithKline, Seqirus and Dynavax have committed to making licensed adjuvants (AS03, MF59 and CpG 1018, respectively) available for use with novel COVID-19 vaccines developed by others. Public information on the specific SARS-CoV-2 antigen(s) used in vaccine

  Vaccine, Adjuvants, Adjuvanted, Adjuvanted vaccines

實證護理步驟 - CGMH

實證問題(例) • 膀胱訓練(i)是否能有效處理婦科手術病人(p)尿失禁 (o)？ • 使用手(i)或機器(c)為copd病人(p)背部扣擊對呼吸 道分泌物清除效果、肺功能及血氧濃度(o)有無不同? • 使用清水(i)或優碘(c)為接受婦科手術後之病人(p)施 行導尿管護理，對泌尿道感染率(o)的發生有無不同?

Teknik Analisis Kuantitatif 1 - UNY

- Wilcoxon - McNemar - Sign Test - Paired/corelated t-test L e b i h d a r i 2 K e l o m p o k I n d e p e n d e n - Kai Kuadrat - Kolmogorov-Smirnov - Kruskall-Wallis - Uji Median - Kai Kuadrat - Analisis Varians (ANAVA) C o r r e l a t e d - Friedman - Kendall's W - Cochran's Q - ANAVA repeat measures

  Tests, Wilcoxon

Syntax - Stata

test the null hypothesis that X 1 ˘X 2. We have a sample of size n 1 from X 1 and another of size n 2 from X 2. The data are then ranked without regard to the sample to which they belong. If the data are tied, averaged ranks are used. Wilcoxon’s test statistic (1945) is the sum of the ranks for the observations in the first sample: T = Xn 1 ...

  Tests, Wilcoxon